Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Other Non-Current Liabilities (2020 - 2025)

RxSight's Other Non-Current Liabilities history spans 5 years, with the latest figure at $3.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 88.24% year-over-year to $3.2 million; the TTM value through Dec 2025 reached $3.2 million, up 88.24%, while the annual FY2025 figure was $3.2 million, 88.24% up from the prior year.
  • Other Non-Current Liabilities reached $3.2 million in Q4 2025 per RXST's latest filing, up from $1.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.2 million in Q4 2025 to a low of $74000.0 in Q4 2023.
  • Average Other Non-Current Liabilities over 4 years is $1.3 million, with a median of $888000.0 recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 2197.3% in 2024, then surged 88.24% in 2025.
  • A 4-year view of Other Non-Current Liabilities shows it stood at $2.6 million in 2021, then crashed by 97.17% to $74000.0 in 2023, then surged by 2197.3% to $1.7 million in 2024, then soared by 88.24% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Other Non-Current Liabilities are $3.2 million (Q4 2025), $1.7 million (Q4 2024), and $74000.0 (Q4 2023).